Barriers to blood pressure control as reported by African American patients

Journal of the National Medical Association

Volumn 101, Issue 6, 2009, Pages 597-603

  Wexler, Randy ^a   Elton, Terry ^b   Pleister, Adam ^a   Feldman, David ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

African Americans; Hypertension

Indexed keywords

SODIUM;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; COMMUNITY; CONTROLLED STUDY; DATA ANALYSIS; EDUCATION PROGRAM; FAMILY; FEMALE; HEALTH CARE SYSTEM; HIGH SCHOOL; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STATISTICS; VALIDITY;

EID: 67650535664     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30947-0     Document Type: Article

References (36)

1. Blood Pressure Lowering Treatment Trialist's Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003;362:1527-1535.
2. Lewington S, Clarke R, Qizilbash N, et al. Specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
3. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297. (Pubitemid 34940740)
4. Chobanian A, Bakris G, Black H, et al. Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Management of High Blood Pressure (JNC-7). Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)
5. American Heart Association. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX: American Heart Association; 2005.
6. Jessup, M., Brozena, S. Medical Progress: Heart Failure. N Engl J Med. 2003; 348:2007-2018.
7. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Dallas, TX: American Heart Association; 2003.
8. Hodgson T, Cohen A. Medical care expenditures for selected circulatory disease: opportunities for reducing national health expenditures. Medical Care. 1999;37:994-1006.
9. Ogden LG, He J, Lydick E, et al. Longterm absolute benefit of lowering blood pressure in hypertensive patients according to JNC VI risk stratification. Hypertension. 2000;35:539-543. (Pubitemid 30108145)
10. Hansson L, Lindholm L, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with hypertension-2 study. Lancet. 1999;354:1751-1756.
11. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas, TX: American Heart Association; 2006.
12. The 2003 Report of the Centers For Disease Control, National Center for Health Statistic, National Health and Nutrition Examination Survey; 2003, Table 66. Health, United States.
13. The 2005 Issue Brief: Policy challenges and opportunities in closing the racial/ethnic divide in health care: Race, Ethnicity & Health Care; March 2005. The Henry J. Kaiser Foundation.
14. The 2002 Report of the Institutes of Medicine: Unequal treatment: Confronting racial and ethnic disparities in healthcare; March 2002. The Institute of Medicine. National Academy of Sciences.
15. Perloff RM, Bonder B, Ray GB, et al. Doctor-patient communication, cultural competence, and minority health. Am Behav Sci. 2006;49:835-852.
16. The 2002 Report of the AHRQ Focus on Research, Disparities in health care; March 2002. Agency for Healthcare Research and Quality Publication number 02-M027.
17. van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Medical Care. 2002;40;SI140-SI151.
18. Ogedegbe G,Mancuso CA, Allegrante JP. Expectations of blood pressure management in hypertensive African American patients: a qualitative study. J Natl Med Assoc. 2004;96:442-449. (Pubitemid 38437168)
19. Lukoschek P. African Americans' beliefs and attitudes regarding hypertension and its treatment: a qualitative study. J Health Care Poor Underserved. 2003;14:566-587. (Pubitemid 38553149)
20. American Heart Association. Heart Disease and Stroke Statistics - 2007 Update. Dallas, TX: American Heart Association; 2007.
21. Horowitz CR, Tuzzio L, Rojas M, et al. How do urban African Americans and Latinos view the influence of diet on hypertension? J Health Care Poor Underserved. 2004;15:631-644.
22. Ogedegbe G, Mancuso CA, Allegrante JP, et al. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African American patients. Journal of Clinical Epidemiology. 2003;56:520-529. (Pubitemid 36842909)
23. Sacks F, Svetkey L, Vollmer W, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344:3-10. (Pubitemid 32064838)
24. Cook NR, Cutler JA, Obaranek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trial of hypertension prevention (TOHP). Br Med J. 2007; doi:1011369/bmj.39147.60489655. (Pubitemid 46724330)
25. Dickinson BD, Havas S. Reducing the population burden of cardiovascular disease by reducing sodium intake. Arch Intern Med. 2007;167:1460-1468.
26. Meneton P Jeunemaitre X, Wardener HE, et al. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85:679-715. (Pubitemid 40404639)
27. Baudin B. Polymorphism in angiotensin II receptor genes and hypertension. Experimental Physiology. 2004;90:277-282.
28. Suzuki H, Yamamoto T, Ikegaya N, et al. A dietary salt intake modulates preogression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. Am J Physiol Renal Physiol. 2004;286:F267-F277. (Pubitemid 38141670)
29. Burneir M, Brunner HR. Angiotensin II receptor antagonists. Lancet. 2000;335:637-645.
30. Azizi M, Menard J. Combined blockade of the rennin-angiotensin system with angiotensin-copnverting enzyme inhibitors, and angiotensin II type 1 receptor antagonists. Circulation. 2004;109:2492-2499. (Pubitemid 38720545)
31. Yusuf S, Sleight P, Pogue J. Effects of an angiotensin-converting-enzyme inhibitior, ramipril, on cardiovascular events in high risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
32. Schmidlin O, Forman A, Sebastian A, et al. Sodium selective salt sensitivity: It's occurrence in blacks. Hypertension. 2007;50:1085-1092. (Pubitemid 350172930)
33. Halbert CH, Armstrong K, Gandy OH, Shaker L. Racial differences in trust in health care providers. Arch Intern Med. 2006;166:896-901.
34. Wexler RK, Feldman D. Addressing Cultural Differences are Important in Reducing Disparities Due to Hypertension. Circulation. 2007;151:477.
35. Johnson RL, Arbelaez JJ, Cooper LA. Racial and ethnic differences in patient perception of bias and cultural competences in health care. J Gen Intern Med. 2004;19:900-902. (Pubitemid 38368458)
36. Johnson RL, Roter D, Powe NR, et al. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Pub Health. 2004;94:2084-2090. (Pubitemid 39578411)